Related Experiment Videos
[Gradually diminishing tumor protection caused by reimplants]
Abstract:
Mice from which a MCA-induced sarcoma has been removed and which are exposed to repeated (every three months) tumoral cell transplants, gradually lose their protection against a certain threshold number of cells. Although the survival period after each transplant is longer than in non-protected animals (those that never received a primary tumor) it is seen that while some of them survive for three months (these are the ones to be re-inoculated with tumoral cells) others die. The proportion of mice which die rises with the number of inoculations received; and among those which die, the proportion of mice without localized tumor or neoplastic dissemination is also progressively higher. We do not know why these mice die at a later and cachectic stage without tumor but in a situation resembling a GVH (graft versus host) reaction. Repeated challenge through re-inoculation induces "bradyphylaxis" (progressively diminishing protection). On histopathological examination intense congestion is found, with haemorrhages in the lungs, liver, spleen and kidneys.
Insights
Repeated tumor cell transplants in mice diminish immune protection, leading to increased mortality and a graft-versus-host-like reaction. This phenomenon, termed "bradyphylaxis," highlights complex immune responses to cancer progression.
Area of Science:
- Immunology
- Oncology
- Pathology
Context:
- Studies investigate the long-term immune response following surgical removal of primary tumors.
- Mice with previously resected MCA-induced sarcomas were subjected to repeated tumor cell challenges.
- The study observed changes in protective immunity and survival rates after serial tumor inoculations.
Purpose:
- To elucidate the mechanisms underlying the loss of tumor-specific immunity after repeated antigen exposure.
- To characterize the pathological outcomes and mortality patterns in mice undergoing serial tumor cell transplants.
- To investigate the potential role of graft-versus-host (GVH) reactions in tumor-bearing hosts.
Summary:
- Mice with resected sarcomas showed diminishing protection against subsequent tumor cell transplants over time.
- Increased mortality was observed with repeated inoculations, with a higher proportion of deaths occurring without detectable tumors or dissemination.
- Histopathological findings included significant congestion and hemorrhages in multiple organs, suggesting systemic inflammatory responses.
Impact:
- Identifies 'bradyphylaxis' as a state of progressively diminishing protection induced by repeated tumor challenge.
- Suggests that tumor recurrence or mortality can occur through mechanisms beyond localized tumor growth, potentially involving immune dysregulation.
- Provides insights into the complex interplay between the host immune system, tumor cells, and long-term cancer management strategies.